COLL FY 2017 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$28M+1564.3% YoY

Gross Profit

$26M90.9% margin

Operating Income

-$75M-264.9% margin

Net Income

-$75M-262.9% margin

EPS (Diluted)

$-2.47

Cash Flow

Operating Cash Flow

-$67M

Free Cash Flow

-$68M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$136M

Total Liabilities

$31M

Stockholders' Equity

$104M

Cash & Equivalents

$119M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$2M	+1564.3%
Gross Profit	$26M	$1M	+1627.7%
Operating Income	-$75M	-$94M	+19.8%
Net Income	-$75M	-$94M	+20.5%